Gilead

Efficacy and Safety of Filgotinib in Adults with Active Non-Infectious Uveitis (Humboldt)

Sponsor:

Gilead Sciences

The primary objective of this study is to evaluate the efficacy of filgotinib versus placebo for the treatment of the signs and symptoms of noninfectious uveitis in participants failing treatment for active noninfectious uveitis.

Approximately 50 centres globally